By preferentially activating the DNA damage checkpoint response to control the cell cycle, boost DNA repair capacity, and decrease radiosensitivity by upregulating the expression of HR genes RAD51-, BRCA1/2-, and CD133-positive glioma stem cells help to develop glioma radioresistance [192, 193]. This evidence concerns the gene BRCA1 and central nervous system cancer.